The peritoneal dialysis market is projected to reach USD 14.16 billion by 2031 from USD 10.04 billion in 2026 at a CAGR of 6.0% during the forecast period.
Favorable healthcare policies in developed markets have greatly increased access to peritoneal dialysis, as many now offer reimbursement for home-based treatments. In most cases, the United States, Canada, and several other European countries have implemented policies that acknowledge the cost-effectiveness and greater benefits of peritoneal dialysis over in-center hemodialysis for patients. Such policies reduce barriers to treatment by providing reimbursement for a significant portion of PD-associated treatment costs.
This could make PD a much more affordable and accessible form of therapy for patients, and reimbursement programs encourage healthcare providers to recommend PD for its flexibility and practicality, especially for those preferring home management of treatment. For instance, in the United States, Medicare's ESRD program encourages wider adoption by providing reimbursements for home dialysis. Likewise, other developed markets are also following and encouraging home dialysis since it reduces hospital admissions, improves patient outcomes, and reduces burdens on healthcare facilities. The financial support that comes with PD has become a reason for the aged and bedridden patients who have been able to live better as a result of reduced immobilization and enhanced personal care.
This places them in a better position to ensure that patients requiring the treatment receive a holistic education on how to carry out procedures safely and effectively at home. Moreover, these professionals provide timely interventions through effective monitoring, thereby improving outcomes and reducing complications as much as possible. Specialized training programs and ongoing professional development in the region further underpin quality care. Such professionalism among healthcare professionals has indeed contributed to success in the introduction and spread of peritoneal dialysis in North America.
Favorable healthcare policies in developed markets have greatly increased access to peritoneal dialysis, as many now offer reimbursement for home-based treatments. In most cases, the United States, Canada, and several other European countries have implemented policies that acknowledge the cost-effectiveness and greater benefits of peritoneal dialysis over in-center hemodialysis for patients. Such policies reduce barriers to treatment by providing reimbursement for a significant portion of PD-associated treatment costs.
This could make PD a much more affordable and accessible form of therapy for patients, and reimbursement programs encourage healthcare providers to recommend PD for its flexibility and practicality, especially for those preferring home management of treatment. For instance, in the United States, Medicare's ESRD program encourages wider adoption by providing reimbursements for home dialysis. Likewise, other developed markets are also following and encouraging home dialysis since it reduces hospital admissions, improves patient outcomes, and reduces burdens on healthcare facilities. The financial support that comes with PD has become a reason for the aged and bedridden patients who have been able to live better as a result of reduced immobilization and enhanced personal care.
The end-stage renal disease segment holds the largest market share in the global peritoneal dialysis market and is expected to grow at the highest CAGR during the forecast period.
Most healthcare systems promote home dialysis options to reduce hospital visits for end-stage renal disease (ESRD), thereby reducing overall healthcare costs. Health care providers would benefit from home peritoneal dialysis by reducing the need for in-center dialysis, thereby conserving hospital facility capacity and minimizing the problems it poses for both facilities and personnel. Home dialysis will also improve patients' lives by giving them control over their treatment. An added advantage of home-based PD is that it is very economical since it saves transportation costs, minimizes susceptibility to infection, and encourages continuity of care, which makes it an attractive modality for health care systems.The home care settings segment accounted for the largest market share in the global peritoneal dialysis market and is expected to grow at the highest CAGR during the forecast period.
Portable, user-friendly dialysis equipment has further improved the safety and ease of treatment for patients in the home setting. Modern peritoneal dialysis machines are well-designed, with intuitive interfaces, automation, and compact size, making them devices that patients can use with relative ease without relying heavily on medical knowledge. Thus, independent, comfortable home-based dialysis has reduced patients' dependence on healthcare professionals. Safety measures have improved with live monitoring and automatic alarms that enhance outcomes best dealt with early, before dangers occur. With those innovations, patients' confidence in managing their care improved, while treatment compliance generally increased.North America is expected to witness a substantial growth rate during the forecast period.
The peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa by region. In 2023, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounted for the largest market share of the peritoneal dialysis market in 2025. North America is the largest regional market for peritoneal dialysis, partly because healthcare providers in the region have been trained to manage this treatment.This places them in a better position to ensure that patients requiring the treatment receive a holistic education on how to carry out procedures safely and effectively at home. Moreover, these professionals provide timely interventions through effective monitoring, thereby improving outcomes and reducing complications as much as possible. Specialized training programs and ongoing professional development in the region further underpin quality care. Such professionalism among healthcare professionals has indeed contributed to success in the introduction and spread of peritoneal dialysis in North America.
A breakdown of the primary participants (supply-side) for the peritoneal dialysis market referred to in this report is provided below:
- By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
- By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
- By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%
Research Coverage
The report evaluates the peritoneal dialysis market and estimates the market size and future growth potential of this market based on various segments, including offerings, modality, disease indication, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.Reasons to Buy the Report
The report will assist market leaders and new entrants with data on the nearest approximations of revenue numbers for the overall market, the peritoneal dialysis market, and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report helps stakeholders understand the market pulse and provides data on key drivers, barriers, and opportunities in the market.This report provides insights into the following points:
- Analysis of key drivers Drivers (rising prevalence of chronic kidney diseases, growing prevalence of diabetes and hypertension, and technological advancements and increased investment in R&D) restraints (underutilization of peritoneal dialysis in low-income and lower-middle-income countries (LLMICs)) opportunities (increasing growth opportunities in emerging economies, and surge in demand for home dialysis treatment), and challenges (growing incidence of treated kidney failure, and shortage of skilled nephrologists in low-income and lower-middle-income countries (LLMICs)).
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global peritoneal dialysis market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by offerings, modality, disease indication, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global peritoneal dialysis market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global peritoneal dialysis market
Table of Contents
1 Introduction
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Industry Trends
6 Technological Advancements, AI-Driven Impact, Patents, Innovations, and Future Applications
7 Regulatory Landscape
8 Customer Landscape & Buyer Behavior
9 Peritoneal Dialysis Market, by Offering
10 Peritoneal Dialysis Market, by Modality
11 Peritoneal Dialysis Market, by Disease Indication
12 Peritoneal Dialysis Market, by End User
13 Peritoneal Dialysis Market, by Region
14 Competitive Landscape
15 Company Profiles
16 Research Methodology
17 Appendix
List of Tables
List of Figures
Companies Mentioned
- Fresenius Medical Care AG
- Vantive
- Davita Inc.
- Terumo Corporation
- Becton, Dickinson and Company
- Utah Medical Products, Inc.
- Mozarc Medical
- Diaverum Ab
- Medionics
- Newsol Technologies Inc.
- Apollo Dialysis Pvt. Ltd.
- U.S. Renal Care, Inc.
- Northwest Kidney Centers
- Relavo
- Mitra Industries Pvt. Ltd.
- Jms Co. Ltd.
- Amecath
- Polymedicure
- Huaren Pharmaceutical
- Awak Technologies
- Innovative Renal Care
- Romsons
- Ssem Mthembu Medical (Pty) Ltd.
- Renax Biomedical Technology Co. Ltd.
- Advin Health Care
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 258 |
| Published | July 2026 |
| Forecast Period | 2026 - 2031 |
| Estimated Market Value ( USD | $ 10.04 Billion |
| Forecasted Market Value ( USD | $ 14.16 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
